Key result
Treatment with quinidine and cilostazol achieved arrhythmia control in a 6-year-old girl with early repolarization syndrome, epilepsy, atrial fibrillation, and a novel KCND3 mutation.
Case Report (n=1)
Highlights the association of epilepsy syndrome and atrial fibrillation with early repolarization syndrome and a novel KCND3 mutation, successfully managed with quinidine and cilostazol.
Answers are grounded in this paper and cite their sources.
May support quinidine-cilostazol in KCND3 early repolarization syndrome; hypothesis-generating and requires prospective validation.
A 6-year-old girl presented with a difficult to control epilepsy syndrome. On evaluation, additional presyncope episodes associated with polymorphic ventricular tachycardia were also noted. A diagnosis of early repolarization syndrome (ERS) was made with an early repolarization pattern on electrocardiogram, documented VT episodes, and clinical presyncope (proposed Shanghai score 7). Paroxysmal atrial fibrillation (AF) was also noted on 24-h Holter recordings. The child was stabilized with isoprenaline infusion and was later discharged with arrhythmia control on quinidine and cilostazol. The genetic evaluation revealed a potassium channel KCND3 gene missense mutation. The case highlights the association of epilepsy syndrome and AF with ERS; the possible association of KCND3 gene mutation with a malignant phenotype; and management issues in a small child.
No takes yet. Share an insight, caveat, or question.
Choubey et al. (2022) conducted a case report in Early repolarization syndrome, epilepsy, and atrial fibrillation (n=1). Quinidine and cilostazol was evaluated. Treatment with quinidine and cilostazol achieved arrhythmia control in a 6-year-old girl with early repolarization syndrome, epilepsy, atrial fibrillation, and a novel KCND3 mutation.
Synapse has enriched 10 related papers. Consider them for comparative context: